Norris Medicines informs about disclosure of material impact of covid-19

01 Jun 2020 Evaluate

Pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, Norris Medicines has informed that it has enclosed the disclosure on material impact of COVID-19 pandemic on the Company.

The above information is a part of company’s filings submitted to BSE.


Norris Medicines Share Price

15.00 0.33 (2.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×